PDLI
Lazard Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-141,208
| Closed | -$458K | – | 1846 |
|
|
2019
Q4 | $458K | Buy |
+141,208
| New | +$458K | ﹤0.01% | 819 |
|
|
2016
Q2 | – | Sell |
-4,043
| Closed | -$13K | – | 1158 |
|
|
2016
Q1 | $13K | Buy |
+4,043
| New | +$13K | ﹤0.01% | 941 |
|
|
2015
Q2 | – | Sell |
-282,653
| Closed | -$1.99M | – | 1237 |
|
|
2015
Q1 | $1.99M | Sell |
282,653
-14,367
| -5% | -$101K | ﹤0.01% | 638 |
|
|
2014
Q4 | $2.29M | Sell |
297,020
-60,000
| -17% | -$463K | ﹤0.01% | 643 |
|
|
2014
Q3 | $2.67M | Buy |
357,020
+51,420
| +17% | +$384K | 0.01% | 588 |
|
|
2014
Q2 | $2.96M | Sell |
305,600
-63,894
| -17% | -$618K | 0.01% | 592 |
|
|
2014
Q1 | $3.07M | Buy |
369,494
+274,415
| +289% | +$2.28M | 0.01% | 546 |
|
|
2013
Q4 | $802K | Buy |
95,079
+45,079
| +90% | +$380K | ﹤0.01% | 726 |
|
|
2013
Q3 | $398K | Buy |
+50,000
| New | +$398K | ﹤0.01% | 751 |
|